| Category: News

Finnish venture capital firm Innovestor has launched a new Life Science & Health fund focusing on early-stage opportunities in the Nordic and Baltic countries. The fund has completed a first closing of € 60 million and aims to increase its capital to 90-120 million euros within 12 months. State-backed Finnish Industry Investment (Tesi) acts as anchor investor in the fund.

The new fund aims to find the next billion dollar innovations from universities and strong research-based companies. A team of accomplished professionals from the sector is responsible for fund investments.